Oddity Tech Ltd ODD

Healthcare SIC 2844 - Perfumes, Cosmetics & Other Toilet Preparations NAICS Manufacturing › Chemical Manufacturing › Soap, Cleaning Compound, and Toilet Preparation Manufacturing derived Nasdaq

Last close —
Market cap —
52-week range — - —

No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.

Valuation FY2025 figures against the last close

P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS1.80

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Revenue $809.8M$647.0M$508.7M$324.5M$222.6M—
Cost of revenue $221.1M$178.7M$150.5M$106.5M$69.4M—
Gross profit $588.7M$468.3M$358.2M$218.1M$153.2M—
SG&A $469.9M$352.7M$283.9M$190.4M$133.7M—
Operating income $118.8M$115.6M$74.3M$27.7M$19.5M—
Pre-tax income $135.7M$127.9M$78.6M$28.9M$18.6M—
Income tax $25.0M$26.4M$20.1M$7.2M$4.7M—
Net income $110.7M$101.5M$58.5M$21.7M$13.9M—
EPS, basic 1.951.771.060.410.26—
EPS, diluted 1.801.641.000.390.26—

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Cash and equivalents $402.2M$50.3M$36.5M$43.1M$30.9M$40.1M
Short-term investments $11.2M$1.9M$1.1M———
Receivables $16.9M$9.2M$9.9M$7.6M——
Inventory $135.2M$99.8M$84.1M$70.2M——
Total current assets $601.8M$223.4M$223.8M$145.9M——
Property, plant and equipment $10.9M$9.8M$9.2M$9.5M——
Goodwill $64.9M$64.9M$64.9M$16.2M$16.2M—
Other intangibles $43.6M$36.5M$36.0M$26.8M——
Total assets $1.14B$438.9M$404.9M$216.4M——
Accounts payable $76.0M$79.1M$56.2M$44.8M——
Short-term debt ———$3.9M——
Total current liabilities $114.8M$124.8M$109.3M$90.4M——
Total liabilities $741.3M$156.6M$121.8M$105.4M——
Retained earnings $314.0M$203.3M$101.8M$43.2M——
Total equity $396.5M$282.3M$283.1M$98.7M$68.6M$52.3M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020
Operating cash flow $87.6M$137.8M$87.5M$39.0M$10.2M—
Depreciation and amortisation $10.7M$9.8M$8.6M$4.4M$4.0M—
Stock-based compensation $33.9M$25.0M$24.1M$6.7M$2.1M—
Capital expenditure $3.9M$3.3M$2.1M$2.3M$2.4M—
Investing cash flow -$267.2M$1.4M-$140.0M-$25.8M-$18.8M—
Financing cash flow $531.3M-$127.3M$48.8M-$246.0K-$318.0K—
Buybacks —$147.3M————

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001104659-26-029490.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. 0 250M 500M 750M 1B Revenue, FY2021: 222.6M Gross profit, FY2021: 153.2M Net income, FY2021: 13.9M Revenue, FY2022: 324.5M Gross profit, FY2022: 218.1M Net income, FY2022: 21.7M Revenue, FY2023: 508.7M Gross profit, FY2023: 358.2M Net income, FY2023: 58.5M Revenue, FY2024: 647M Gross profit, FY2024: 468.3M Net income, FY2024: 101.5M Revenue, FY2025: 809.8M Gross profit, FY2025: 588.7M Net income, FY2025: 110.7M FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2020FY2021FY2022FY2023FY2024FY2025
Revenue — $222.6M $324.5M $508.7M $647.0M $809.8M
Gross profit — $153.2M $218.1M $358.2M $468.3M $588.7M
Net income — $13.9M $21.7M $58.5M $101.5M $110.7M

Others in SIC 2844

TickerCompanyMarket capP/ERevenue growth
CL COLGATE PALMOLIVE CO $74.97B 35.8x 1.4%
EL ESTEE LAUDER COMPANIES INC $39.37B 217.3x 5.0%
KVUE Kenvue Inc. $37.59B 25.8x -2.1%
ELF e.l.f. Beauty, Inc. $6.74B 259.6x 24.6%
IPAR INTERPARFUMS INC $3.69B 22.0x 2.5%
COTY COTY INC. $2.84B — -1.5%
EPC EDGEWELL PERSONAL CARE Co $1.29B 52.9x -1.3%
WALD Waldencast plc $100.3M — -0.7%